Cover - USD ($) |
12 Months Ended | ||
---|---|---|---|
Mar. 31, 2025 |
Jul. 15, 2025 |
Sep. 30, 2024 |
|
Cover [Abstract] | |||
Document Type | 10-K/A | ||
Amendment Flag | true | ||
Amendment Description | This Amendment No. 1 on Form 10-K/A to the Annual Report on Form 10-K of Biotricity Inc. for the year ended March 31, 2025, originally filed with the Securities and Exchange Commission on July 15, 2025 (the “Original Filing”), is being filed to correct certain clerical data entry errors that inadvertently occurred on editing in the Original Filing. | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Document Period End Date | Mar. 31, 2025 | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2025 | ||
Current Fiscal Year End Date | --03-31 | ||
Entity File Number | 001-40761 | ||
Entity Registrant Name | BIOTRICITY INC. | ||
Entity Central Index Key | 0001630113 | ||
Entity Tax Identification Number | 30-0983531 | ||
Entity Incorporation, State or Country Code | NV | ||
Entity Address, Address Line One | 203 Redwood Shores Parkway | ||
Entity Address, Address Line Two | Suite 600 | ||
Entity Address, City or Town | Redwood City | ||
Entity Address, State or Province | CA | ||
Entity Address, Postal Zip Code | 94065 | ||
City Area Code | 800 | ||
Local Phone Number | 590-4155 | ||
Title of 12(g) Security | Common Stock, Par Value $0.001 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 2,787,999 | ||
Entity Common Stock, Shares Outstanding | 26,567,769 | ||
Documents Incorporated by Reference [Text Block] | None | ||
ICFR Auditor Attestation Flag | false | ||
Document Financial Statement Error Correction [Flag] | false | ||
Auditor Firm ID | 5828 | ||
Auditor Opinion [Text Block] | We have audited the accompanying consolidated balance sheets of Biotricity Inc. and its subsidiary (the Company) as of March 31, 2025 and 2024 and the related consolidated statements of operations and comprehensive loss, mezzanine equity and stockholders’ deficiency, and cash flows for each of the years in the two-year period ended March 31, 2025 and related notes (collectively referred to as the financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as at March 31, 2025 and 2024 and the results of its operations and its cash flows for each of the years in the two-year period ended March 31, 2025, in conformity with accounting principles generally accepted in the United States of America. | ||
Auditor Name | SRCO Professional Corporation | ||
Auditor Location | Richmond Hill, Ontario, Canada |